Condition: Cardiac Disease · Bleeding Postoperative · Sponsor: University of Colorado, Denver
Autologous blood transfused at the end of cardiopulmonary bypass will reduce total blood loss 24 hours after surgery and improve mitochondrial oxygen delivery measured by plasma succinate levels. The study design is a prospective randomized interventional trial of transfusion of fresh autologous whole blood versus standard of care expectant management of bleeding during elective cardiac surgery.
This description comes directly from the study's public registry record.
Nathan J Clendenen, M.D. · 720-848-6709 · nathan.clendenen@cuanschutz.edu
Nick Naughton, B.A · 720-848-6709 · nick.naughton@cuanschutz.edu
Always discuss trial participation with your own doctor first.
| University of Colorado Hospital | Aurora, Colorado, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03204357